Dr. med. Harald H.H.W. Schmidt is a medical doctor and pharmacist and Professor and Chair of Pharmacology & Personalised Medicine at Maastricht University’s Faculty of Health, Medicine and Life Sciences. He led a research program as European Research Council (ERC) Advanced Investigator, which translated into a current ERC Proof-of-Concept grant to develop a first-in-class neuroprotective therapy for ischemic stroke. He co-led a EUROSTAR programme which led to the development and commercialisation of a NOX4 inhibitor. As a science leader, he founded/led two European Science Foundation COST actions, one on reactive oxygen (EUROS), one on Systems Medicine. He now co-coordinates the EU-funded Horizon 2020 programme REPO-TRIAL on Systems Medicine and is work package leader in the EU-funded Horizon 2020 programme FeatureCloud. Before Maastricht, prof. Schmidt had worked in Australia, Germany and USA in different academic and business leadership positions. These include chair of Monash University’s Centre for Vascular Health, Australia, Maastricht University Faculty of Medicine innovation platform, the Netherlands, different chairs in pharmacology and director of a drug discovery CRO at TransMIT, Giessen, Germany. He also co-founded and for two years led as CEO Vasopharm GmbH, a drug discovery company now entering into phase III clinical development. His research focuses on cardiovascular and neurological disease mechanisms, target validation, drug and biomarker discovery, personalised and network medicine. Professor Schmidt has published over 200 peer-reviewed papers, reviews, books and patents (Hirsch-index of 95). He was member of the Executive Board of the European Association of Systems Medicine (EASyM), founded the International Society of Systems and Network Medicine (IASyM), co-founded and is co-editor-in-chief of the journal Network and Systems Medicine. He has been awarded the Roche Molecular Biochemicals Research Prize for Cell Biology, the Phoenix Research Prize in Pharmacy, and the Pro Scientia Prize. He is officially registered as policy advisor at the German Parliament (Deutscher Bundestag), co-founder of the patient network patientenwiewir.de, and advises the patient network dopanet.org.
Prof. Dr. med. Harald HHW Schmidt